iStock Rating

C
Details...
Enter Symbol click to research

Pfizer, Inc. (NYSE: PFE)

Sector: Medical

Current Price : $28.70

52 Week Low
$21.60
52 Week High
$31.06
 

PFIZER INC(NYSE:PFE)
Pfizer Inc is a research-based, global pharmaceutical company that discovers and develops innovative, value-added products that improve the quality of life of people around the world and help them enjoy longer, healthier, and more productive lives. Pfizer has three business segments: health care, animal health and consumer health care. Its products are available in numerous countries. (Company Press Release)
# Employees: 91500
Address: 235 E 42ND ST,NEW YORK,NY,USA
Phone: 2125732323
Fax: 2125737851
Website: www.pfizer.com
Email:
Sector: Medical
Industry: Large Cap Pharma
Executive Officers
Ian C. Read (Chairman and Chief Executive Officer)
Olivier Brandicourt (President and General Manager)
Frank A. D'Amelio (Executive Vice President; Business Operations and)
Mikael Dolsten (President of Worldwide Research and Development)
Charles H. Hill III (Executive Vice President,)
Dividend
Ex-Dividend Date: 1/30/2013
Annual Dividend: $0.96
Current Dividend Yield: $3.09
Dividend Paid (3 months): $0.24
Indicated Dividend: N/A
Earnings
Last Earnings Date: 12/31/2012
Next Earnings Date(Expected): 4/30/2013
Mean EPS (Next Qtr): $0.58
Mean EPS (Year): $2.28
Mean Estimate(Long Term): $4.19
P/E Ratio(Based on EPS estimate): 13.650
Number of Estimates: 13
Shares Performance
Period pfe Compare to S&P
YTD 23.85 % 13.57 %
4 Weeks 9.44 % 9.56 %
12 Weeks 15.04 % 11.17 %
Shares Information
Analyst Coverage: Y
Avg Volume: 30658266
Shares Outstanding: 7185M
Market Cap: $223.19B
52 Week High: $31.06
52 Week Low: $21.60
P/E Ratio: 14.120
PEG Ratio: 3.260
Split: On 7/1/1999 pfe split by factor of 3.000
Earnings Performance
EPS Growth in Last Quarter: -11.32 %
EPS Growth in Last Year: -6.00 %
Sales Growth in Last Quarter: 7.81 %
Sales Growth in Last Quarter: -10.02 %
Financials
Qtr Book Value: $2.80
Cash Flow/Share: $9.49
Change in Payout Ratio: -0.010
Price/Sales: -0.010
Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia. Advertisement partners Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.